看网页链接" target="_blank">$新基(CELG)$  的shopping list，非常有趣。出自George Golumbeski和Tom Daniel的合作，BD和R&D无嫌隙的组合，是杀伤力很强的一件事。”They are known for their shared curiosity in leading-edge science, their close working relationship, and their power to get deals done inside the company.”

*Acquisitions done: Pharmion,Abraxis Bioscience, Gloucester Pharmaceuticals, and Avila Therapeutics.

*IPOs that have Celgene’s fingerprints all over them: $EPIZYME INC(EPZM)$  , ($AGIOS PHARMACEUTICALS INC(AGIO)$  ), and $BLUEBIRD BIO INC(BLUE)$  .

*In the future:Celgene has gotten its hooks into some of the best venture-backed companies in the hottest areas of biomedicine. These young companies are leaders in epigenetic-based drug development, cancer metabolism, antibody drugs, gene therapy, immunotherapy, and regenerative medicine. If even one-fourth or one-fifth of these companies do what they say they are aspiring to do, Celgene will win big.


–Company reports, Celgene regulatory filings